Appalachian Cardiovascular Associates

Fort Payne, Alabama 35968

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Disease, Essential Hypertension, Optim Lead Insulation Related Adverse Events

Studies at this site

• Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension — Completed
• Lead Registry for Optim Leads — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early